Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography

We evaluated the effect of anti-androgen therapy for benign prostatic hypertrophy on 33 patients who had undergone transrectal prostatic ultrasonography both before and after administration of anti-androgenic drugs in our clinic. Patients treated with chlormadinone acetate (CMA) orally, or TSAA-291...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 36(1990), 12 vom: 19. Dez., Seite 1423-7
1. Verfasser: Kazama, T (VerfasserIn)
Weitere Verfasser: Mizuno, I, Takamine, T, Umeda, K, Terada, T, Ishikawa, S, Fuse, H, Katayama, T
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1990
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Androgen Antagonists Chlormadinone Acetate 0SY050L61N Nandrolone 6PG9VR430D oxendolone MN4I850D4P
Beschreibung
Zusammenfassung:We evaluated the effect of anti-androgen therapy for benign prostatic hypertrophy on 33 patients who had undergone transrectal prostatic ultrasonography both before and after administration of anti-androgenic drugs in our clinic. Patients treated with chlormadinone acetate (CMA) orally, or TSAA-291 intramuscularly showed a significant reduction in the prostatic weight. However, this reduction was not correlated with the degree of symptomatic improvement. In addition, patients who showed no symptomatic improvement despite a reduction in the prostatic weight often had prostatic stones or small inflammatory cell infiltrations in their prostatic tissue. Therefore, the coexistence of prostatitis or bladder neck obstruction with prostatic hypertrophy may contribute to the lack of symptomatic improvement in such patients
Beschreibung:Date Completed 12.04.1991
Date Revised 23.11.2016
published: Print
Citation Status MEDLINE
ISSN:0018-1994